|
⚲
|
| Keyboard |
| Schoenbart Alan Wayne
✚
|
|
|---|---|
| CIK # | 0001313629 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001313629] | |
| 4 | [0001313629] | |
| SC 13D | [0001313629] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Schoenbart Alan Wayne | Echo Therapeutics Inc | [2017-04-06] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Schoenbart Alan Wayne | |
| Echo Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Echo Therapeutics Inc ECTE
Common Stock, par value $.01
|
2017-03-21 | Grant | 100,000 | $0.00 | |
|
Echo Therapeutics Inc ECTE
Stock Option (Right to Buy) · derivative
|
2017-03-21 | Grant | 500,000 | $0.00 | |
|
Echo Therapeutics Inc ECTE
Common Stock, par value $.01
|
2016-11-25 | Tax withheld | 28,000 | $0.34 | 9,520 |
|
Echo Therapeutics Inc ECTE
Common Stock
|
2016-03-01 | Grant | 100,000 | $0.00 | |
|
Echo Therapeutics Inc ECTE
Options (Right to Buy) · derivative
|
2016-03-01 | Grant | 150,000 | $0.00 | |
|
Echo Therapeutics Inc ECTE
Common Stock
|
2015-05-20 | Buy | 2,500 | $1.44 | 3,600 |